Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib in Pediatric Langerhans Cell Histiocytosis
NCT06582745Phase 2Recruiting
- Sponsor
- Cook Children's Health Care System
- Start
- Jun 2024
- Primary completion
- Jun 2039
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib in Langerhans cell histiocytosis (LCH), sponsored by Cook Children's Health Care System. Started Jun 2024; status: recruiting.
02
Drugs
trametinib
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on NCT06582745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06582745.